Abstract
Background
The expression of microRNAs (miRNAs) in the serum of B-cell acute lymphoblastic leukemia (B-ALL) patients is abnormal. Nevertheless, the underlying mechanism remains unclear. Recent studies indicate that the methylation state of circulating cell-free DNA (cfDNA) is different between cancer patients and healthy individuals. Therefore, we speculate that abnormal expression of miRNA may be associated with cfDNA methylation.
Methods
A green fluorescent protein (GFP) labeled B-ALL transplantation animal model was established to explore the relationship between the miRNA expression and cfDNA methylation of the related gene. Quantitative real-time PCR (qRT-PCR) was used to detect the expression levels of miRNAs. Further, cfDNA methylation levels of the related genes were evaluated through bisulfite sequencing polymerase chain reaction (BSP).
Results
The expression levels of miR-196b, miR-203, miR-34a-5p, miR-335-3p, miR-34b-5p, miR-615, miR-375-3p and miR-193b-5p in the serum of the model mice were significantly lower than those of the control group (P < 0.05). The methylation level of miR-196b promoter in cfDNA of the model group was significantly lower than that of the control group (P < 0.05), whereas no significant difference was noted in miR-203 promoter. The methylation levels of miR-196b and miR-203 coding region in cfDNA of the model group were significantly higher than those of the control group (P < 0.05).
Conclusions
These results showed that CpG island hypermethylation in the miRNA coding region of cfDNA is related to the low expression of miR-196b and miR-203.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this article.
References
Sun W, Malvar J, Sposto R, Verma A, Wilkes JJ, Dennis R, Heym K, Laetsch TW, Widener M, Rheingold SR et al (2018) Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia 32(11):2316–2325. https://doi.org/10.1038/s41375-018-0094-0
Li C, Zhao T, Nie L, Zou Y, Zhang Q (2020) MicroRNA-223 decreases cell proliferation, migration, invasion, and enhances cell apoptosis in childhood acute lymphoblastic leukemia via targeting forkhead box O 1. Biosci Rep. https://doi.org/10.1042/BSR20200485
Swellam M, Hashim M, Mahmoud MS, Ramadan A, Hassan NM (2018) Aberrant expression of some circulating miRNAs in childhood acute lymphoblastic leukemia. Biochem Genet 56(4):283–294. https://doi.org/10.1007/s10528-018-9844-y
Suzuki H, Maruyama R, Yamamoto E, Kai M (2012) DNA methylation and microRNA dysregulation in cancer. Mol Oncol 6(6):567–578. https://doi.org/10.1016/j.molonc.2012.07.007
Hua X, Tang R, Xu X, Wang Z, Xu Q, Chen L, Wingender E, Li J, Zhang C, Wang J (2018) mirTrans: a resource of transcriptional regulation on microRNAs for human cell lines. Nucleic Acids Res 46(D1):D168–D174. https://doi.org/10.1093/nar/gkx996
Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE (2008) Chromatin structure analyses identify miRNA promoters. Genes Dev 22(22):3172–3183. https://doi.org/10.1101/gad.1706508
Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV (2009) Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4(4):e5279. https://doi.org/10.1371/journal.pone.0005279
Chang SC, Li AF, Lin PC, Lin CC, Lin HH, Huang SC, Lin CH, Liang WY, Chen WS, Jiang JK et al (2020) Clinicopathological and molecular profiles of sporadic microsatellite unstable colorectal cancer with or without the CpG island methylator phenotype (CIMP). Cancers. https://doi.org/10.3390/cancers12113487
Barchitta M, Maugeri A, Magnano San Lio R, Favara G, La Rosa MC, La Mastra C, Quattrocchi A, Agodi A (2019) Dietary patterns are associated with leukocyte LINE-1 methylation in women: a cross-sectional study in southern Italy. Nutrients. https://doi.org/10.3390/nu11081843
Morales S, Monzo M, Navarro A (2017) Epigenetic regulation mechanisms of microRNA expression. Biomol Concepts 8(5–6):203–212. https://doi.org/10.1515/bmc-2017-0024
Gilyazova I, Ivanova E, Gilyazova G, Sultanov I, Izmailov A, Safiullin R, Pavlov V, Khusnutdinova E (2021) Methylation and expression levels of microRNA-23b/-24-1/-27b, microRNA-30c-1/-30e, microRNA-301a and let-7g are dysregulated in clear cell renal cell carcinoma. Mol Biol Rep 48(7):5561–5569. https://doi.org/10.1007/s11033-021-06573-w
Baburaj G, Damerla RR, Udupa KS, Parida P, Munisamy M, Kolesar J, Rao M (2020) Liquid biopsy approaches for pleural effusion in lung cancer patients. Mol Biol Rep 47(10):8179–8187. https://doi.org/10.1007/s11033-020-05869-711
Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P (2000) The origin and mechanism of circulating DNA. Ann N Y Acad Sci 906:161–168. https://doi.org/10.1111/j.1749-6632.2000.tb06608.x
Zeng H, He B, Yi C, Peng J (2018) Liquid biopsies: DNA methylation analyses in circulating cell-free DNA. J Genet Genom 45(4):185–192. https://doi.org/10.1016/j.jgg.2018.02.007
Gao YJ, He YJ, Yang ZL, Shao HY, Zuo Y, Bai Y, Chen H, Chen XC, Qin FX, Tan S, Wang J, Wang L, Zhang L (2010) Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia. Clin Chem Lab Med 48(11):1651–1656. https://doi.org/10.1515/CCLM.2010.311
Luo H, Wei W, Ye Z, Zheng J, Xu RH (2021) Liquid biopsy of methylation biomarkers in cell-free DNA. Trends Mol Med 27(5):482–500. https://doi.org/10.1016/j.molmed.2020.12.011
Londra D, Mastoraki S, Bournakis E, Zavridou M, Thanos A, Rampias T, Lianidou ES (2021) USP44 promoter methylation in plasma cell-free DNA in prostate cancer. Cancers 13(18):4607. https://doi.org/10.3390/cancers13184607
Zhang X, Zhao D, Yin Y, Yang T, You Z, Li D, Chen Y, Jiang Y, Xu S, Geng J, Zhao Y, Wang J, Li H, Tao J, Lei S, Jiang Z, Chen Z, Yu S, Fan JB, Pang D (2021) Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis. NPJ Breast Cancer 7(1):106. https://doi.org/10.1038/s41523-021-00316-7
Hlady RA, Zhao X, Pan X, Yang JD, Ahmed F, Antwi SO, Giama NH, Patel T, Roberts LR, Liu C, Robertson KD (2019) Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA. Theranostics 9(24):7239–7250. https://doi.org/10.7150/thno.35573
Liu L, Sun L, Li C, Li X, Zhang Y, Yu Y, Xia W (2015) Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients. Bio-Med Mater Eng 26(Suppl 1):S2217–S2222. https://doi.org/10.3233/BME-151527
Hu T, Qi H, Li P, Zhao G, Ma Y, Hao Q, Gao C, Zhang Y, Wang C, Yang M et al (2015) Comparison of GFP-expressing imageable mouse models of human esophageal squamous cell carcinoma established in various anatomical sites. Anticancer Res 35(9):4655–4663
Hoffman RM, Bouvet M (2016) Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP. Cancer Lett 380(1):349–355. https://doi.org/10.1016/j.canlet.2015.12.021
Allocca G, Hughes R, Wang N, Brown HK, Ottewell PD, Brown NJ, Holen I (2019) The bone metastasis niche in breast cancer-potential overlap with the hematopoietic stem cell niche in vivo. J Bone Oncol 17:100244. https://doi.org/10.1016/j.jbo.2019.100244
Jalalie L, Rezaie MJ, Jalili A, Rezaee MA, Vahabzadeh Z, Rahmani MR, Karimipoor M, Hakhamaneshi MS (2019) Distribution of the CM-Dil-labeled human umbilical cord vein mesenchymal stem cells migrated to the cyclophosphamide-injured ovaries in C57BL/6 mice. Iran Biomed J 23(3):200–208. https://doi.org/10.29252/.23.3.200
Sun YU, Nishino H, Zhao M, Miyake K, Sugisawa N, Yamamoto J, Tashiro Y, Inubushi S, Hamada K, Zhu G et al (2020) A non-invasive Imageable GFP-expressing mouse model of orthotopic human bladder cancer. In Vivo (Athens, Greece) 34(6):3225–3231. https://doi.org/10.21873/invivo.12158
Xu L, Guo Y, Yan W, Cen J, Niu Y, Yan Q, He H, Chen CS, Hu S (2017) High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome. EXCLI J 16:197–209. https://doi.org/10.17179/excli2016-707
Shafik RE, Abd El Wahab N, Mokhtar MM, El Taweel MA, Ebeid E (2020) Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia. Asian Pac J Cancer Prev 21(11):3429–3434. https://doi.org/10.31557/APJCP.2020.21.11.3429
Bhatia S, Kaul D, Varma N (2010) Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia. Mol Cell Biochem 340(1–2):97–106. https://doi.org/10.1007/s11010-010-0406-9
Liu Y, Zheng W, Song Y, Ma W, Yin H (2013) Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis. PLoS ONE 8(7):e68442. https://doi.org/10.1371/journal.pone.0068442
Tsai KW, Hu LY, Wu CW, Li SC, Lai CH, Kao HW, Fang WL, Lin WC (2010) Epigenetic regulation of miR-196b expression in gastric cancer. Genes Chromosom Cancer 49(11):969–980. https://doi.org/10.1002/gcc.20804
Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL et al (2009) Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113(14):3314–3322. https://doi.org/10.1182/blood-2008-04-154310
Schotte D, Lange-Turenhout EA, Stumpel DJ, Stam RW, Buijs-Gladdines JG, Meijerink JP, Pieters R, Den Boer ML (2010) Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica 95(10):1675–1682. https://doi.org/10.3324/haematol.2010.023481
El-Osaily HH, Ibrahim IH, Essawi ML, Salem SM (2021) Impact of miRNAs expression modulation on the methylation status of breast cancer stem cell-related genes. Clin Transl Oncol. https://doi.org/10.1007/s12094-020-02542-0
Chim CS, Wong KY, Leung CY, Chung LP, Hui PK, Chan SY, Yu L (2011) Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J Cell Mol Med 15(12):2760–2767. https://doi.org/10.1111/j.1582-4934.2011.01274.x
Glaich O, Parikh S, Bell RE, Mekahel K, Donyo M, Leader Y, Shayevitch R, Sheinboim D, Yannai S, Hollander D et al (2019) DNA methylation directs microRNA biogenesis in mammalian cells. Nat Commun 10(1):5657. https://doi.org/10.1038/s41467-019-13527-1
Acknowledgements
This study was supported by National Science Funding of China (Grant No. 81201354), Science and Technology Development Program of Jilin Province (Grant No. 20200403118SF), Suzhou Institute of Biomedical Engineering and Technology (SIBET) of the Chinese Academy of Sciences-Jilin Science and Technology Cooperation Project (Grant No. E055PY03) and Beihua University Graduate Innovation Program (Grant No. 2019-062).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by YDW, YHW, HTH, XYF and TQW. The manuscript was written by YDW and reviewed by LML and WX. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This manuscript does not report studies involving human participants. The use of animals and sample collection procedures were in accordance with the ethical standards. Approval was obtained from the Institutional Animal Care and Use Committee of Beihua University.
Informed consent
All authors consent to this manuscript submission.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, Y., Wang, Y., Hui, H. et al. MicroRNA expression is deregulated by aberrant methylation in B-cell acute lymphoblastic leukemia mouse model. Mol Biol Rep 49, 1731–1739 (2022). https://doi.org/10.1007/s11033-021-06982-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06982-x